Press Release Archive - Product News

Product News

06.24.2004
Forest Discusses Disclosure of Citalopram Clinical Trial Data in Children and Adolescents
05.06.2004
Depressed Patients Showed Improvement with Lexapro(TM) After Failure with Initial SSRI Treatment
05.06.2004
Namenda(TM) (memantine HCl) Provides Functional and Behavioral Benefits in Patients with Moderate to Severe Alzheimer's Disease
04.28.2004
New Data Highlight Positive Effect of Namenda(TM) on Brain Activity in Patients With Mild to Moderate Alzheimer's Disease
04.16.2004
Forest Laboratories Receives Notification of ANDA Filing For a Generic Equivalent of Lexapro(R)
03.15.2004
Lexapro(R) as Effective as Paxil(R) and Well Tolerated in the Treatment of Generalized Anxiety Disorder
03.15.2004
ChemoCentryx and Forest Laboratories to Collaborate on Development and Commercialization of Novel Oral Rheumatoid Arthritis and Multiple Sclerosis Therapeutics
02.23.2004
Namenda(TM) Shows Benefit in Behavioral Disturbances Associated With Moderate to Severe Alzheimer's Disease
02.23.2004
Researchers Report Namenda(TM) Provides Significant Benefits as Monotherapy to Patients With Mild to Moderate Alzheimer's Disease
01.13.2004
Namenda(TM) (memantine HCl), First Drug Approved For Treatment of Moderate to Severe Alzheimer's Disease Now Available Nationwide